Format

Send to

Choose Destination

[Use of enerion in psychovegetative syndrome with pronounced asthenia].

[Article in Russian]

Abstract

Enerion was used in the treatment of 40 patients with psychovegetative syndrome and asthenia. Before treatment, the patients have pronounced asthenia appearances, anxiety disorders, relevant autonomic disorders, mild depression and decrease of working capacity, attention concentration and memory. The treatment was conducted as monotherapy during 28 days with enerion dosage 400 mg/day. After treatment, expression of autonomic and asthenic disorders was reduced significantly, along with improvement of psychometric and neurophysiological indices. High efficacy of the medication was detected in 75% of the patients and moderate one--in 25%. The drug was well-tolerated.

PMID:
14628585
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center